Cardiovascular Diseases, Nurse's Role, Smoking Behaviors, Smoking Cessation
Conditions
Brief summary
The purpose of this randomized controlled pilot study is to test whether an in-hospital nurse-led smoking cessation intervention increases the refferal rate to healty life-centers in the municipalities. We will also describe the proportion who succeed in quitting smoking between the intervention group and the control group and obtain new knowledge about the patient and system factors of importance for participation to healty life-centers and for successful and unsuccessful smoking cessation.
Interventions
BEHAVIORALbehavioural and cessation aids
information, motivational interview, refferal to healty life-centers, free cessation aids
Sponsors
University of Oslo
Norwegian Directorate of Health
Oslo University Hospital
Norwegian Institute of Public Health
Vestre Viken Hospital Trust
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Outcomes Assessor)
Intervention model description
patients were randomized to an in-hospital nurse-led smoking cessation intervention with prescription of free cessation aids and systematic referrral to healthy life-centeres or usual care
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
(all): * Age\> 18 years and smokes at least 1 cigarette daily * Hospitalized with a cardiovascular event (i.e. myocardial infarction, heart failure, unstable or stable angina, achyarrhythmias, bradyarrhythmias, carotid stenosis or claudication with need for peripheral revascularization) * Sign informed consent and is expected to participate according to ICH / GCP
Exclusion criteria
(none of these): * Does not meet the criteria to participate in the pilot project, i.e. patients who do not usually live or work in the Vestre Viken catchment area * Chronic renal failure stage 4 or known allergic reaction to varenicline . Any condition (e.g. psychosis, alcohol abuse, dementia) or situation that may pose a significant risk to the participant, confuse the results or make participation unethical * Lack of Norwegian and English knowledge * Short life expectancy (\<12 months)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Differences in participation rate at healthy life-centers between the intervention group and the control group measured by telephone interview with personnell at the healthy life-centers | 8-12 weeks after randomization | Differences in participation rate at healthy life-centers between the intervention group and the control group measured by telephone interview with personnell at the healthy life-centers |
| Differences in use of smoking cessation aids between the intervention group and the control group | 8-12 weeks after randomization | Differences in use of smoking cessation aids between the intervention group and the control group measued by patient self-report and collected from the prescription mediator in the hospital record |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Difference in point prevalence of smoke-free (no cigarettes last 7 days) after 6 months | 12 weeks after randomization | Difference in point prevalence of smoke-free (no cigarettes last 7 days) after 6 months measured with self-reported questionnaires according to the Russell Standard |
| Difference between the groups in proportion who quit smoking between the groups | 12 weeks after randomization | Difference between the groups in proportion who quit smoking between the groups measured by the level of carbon monoxide in the exhaled air |
Countries
Norway
Outcome results
None listed